Study of M5049 in DM and PM Participants (NEPTUNIA)
Conditions: Dermatomyositis; Polymyositis Interventions: Drug: M5049 high dose; Drug: Placebo Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2022 Category: Research Source Type: clinical trials